Cardiac Ambulatory Monitoring Market Report 2026

The cardiac ambulatory monitoring market size has grown strongly in recent years. It will grow from $14.93 billion in 2025 to $15.76 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing diagnosis of cardiac arrhythmias, wider availability of portable ecg devices, growth of outpatient cardiac monitoring services, expansion of ambulatory care facilities, rising physician preference for long-term monitoring.

The cardiac ambulatory monitoring market size is expected to see strong growth in the next few years. It will grow to $19.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing integration of ai-assisted rhythm analysis, growing demand for telecardiology services, expansion of home healthcare monitoring, rising use of mobile cardiac telemetry, increasing adoption of digital health platforms. Major trends in the forecast period include increasing adoption of long-term wearable monitoring devices, rising demand for home-based cardiac monitoring, growing use of wireless and patch-based ecg systems, expansion of continuous remote arrhythmia detection, enhanced focus on patient comfort and compliance.

The increasing prevalence of cardiovascular disease is expected to drive the growth of the cardiac ambulatory monitoring market in the coming years. Cardiovascular disease (CVD) encompasses a range of disorders affecting the heart and blood vessels, including heart attacks, strokes, and heart failure. These conditions generally result from blockages in blood vessels or irregularities in heart function. Factors such as unhealthy diets, sedentary lifestyles, smoking, stress, and an aging population contribute to the prevalence of cardiovascular disease. Moreover, conditions like obesity, diabetes, and hypertension further increase its incidence. Cardiac ambulatory monitoring enables continuous tracking of heart activity, helping to identify irregularities early in patients with cardiovascular disease. It supports more effective management of heart conditions by providing real-time diagnosis and monitoring without the need for frequent hospital visits. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that around 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. By 2030, this number could rise by 1 million, and by 2040, it may increase by 2 million compared to current figures. As a result, the prevalence of cardiovascular disease is contributing to the expansion of the cardiac ambulatory monitoring market.

Key players in the cardiac ambulatory monitoring market are concentrating on developing innovative solutions, including artificial intelligence (AI) and Bluetooth-enabled electrocardiogram devices, to improve patient monitoring and data accuracy. Artificial intelligence (AI) and Bluetooth-enabled electrocardiogram devices are advanced medical tools that utilize AI algorithms for real-time analysis of heart data and employ Bluetooth technology to wirelessly transmit information to healthcare providers. For instance, in September 2024, AliveCor Inc., a US-based company offering remote cardiac care services, introduced the KardiaMobile Card, providing users with a portable and convenient tool for real-time heart monitoring, particularly for detecting arrhythmias and managing heart conditions directly from their wallet. This device makes heart health data readily accessible to patients, enabling early detection of heart problems and helping reduce the economic impact of cardiovascular diseases.

In May 2024, WearLinq Inc., a US-based company offering wearable health monitoring and diagnostic solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This strategic acquisition is set to strengthen WearLinq's nationwide clinical services and broaden access to its FDA-cleared eWave 6-lead wearable ECG monitor, enhancing cardiac diagnostics and positioning the company as a market leader. AMI Cardiac Monitoring LLC is a US-based independent diagnostic testing facility specializing in ambulatory cardiac monitoring.

Major companies operating in the cardiac ambulatory monitoring market are Abbott Laboratories, Medtronic PLC, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Biotronik SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Schiller AG, iRhythm Technologies Inc., ZOLL Medical Corporation, Medicomp Inc., AliveCor Inc., QT Medical Inc., InfoBionic Inc., VivaLNK Inc., Cardiomo Inc., WebCardio LLC, Applied Cardiac Systems, ACS Diagnostics Inc.

North America was the largest region in the cardiac ambulatory monitoring market in 2025. The regions covered in the cardiac ambulatory monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac ambulatory monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the cardiac ambulatory monitoring market by increasing costs of imported sensors, wireless communication modules, batteries, and microprocessors used in wearable and implantable monitoring devices. Hospitals, cardiac care centers, and home care providers in North America and Europe are most affected due to dependence on imported electronic components, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising device prices and extending replacement cycles for monitoring equipment. At the same time, they are encouraging localized device assembly, regional electronics sourcing, and innovation in cost-efficient ambulatory monitoring solutions.

The cardiac ambulatory monitoring market research report is one of a series of new reports that provides cardiac ambulatory monitoring market statistics, including cardiac ambulatory monitoring industry global market size, regional shares, competitors with a cardiac ambulatory monitoring market share, detailed cardiac ambulatory monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac ambulatory monitoring industry. This cardiac ambulatory monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiac ambulatory monitoring involves the continuous tracking and evaluation of a patient's heart activity while they carry out their daily routines outside a clinical environment. This type of monitoring is commonly employed to identify arrhythmias, assess the effectiveness of cardiac treatments, and evaluate overall heart health over a prolonged period.

The primary forms of cardiac ambulatory monitoring include electrocardiogram (ECG) devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. Electrocardiogram (ECG) devices are medical tools designed to measure and record the heart's electrical activity, providing crucial information for diagnosing cardiac conditions. This field includes specialties such as single-specialty and multi-specialty practices. The end users of these monitoring devices comprise hospitals, ambulatory surgical centers, specialty clinics, cardiac care centers, and home care environments.

The cardiac ambulatory monitoring market consists of revenues earned by entities by providing services such as holter monitoring, patch electrocardiogram monitoring, mobile cardiac telemetry (MCT), and wireless remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac ambulatory monitoring market also includes sales of remote patient monitoring systems, wearable fitness trackers, and cardiac rehabilitation monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.